ubenimex has been researched along with Carcinoma, Epidermoid in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, S; Miyahara, R; Nagai, S; Takahashi, R; Takenaka, K; Tanaka, F; Wada, H | 1 |
Genka, K; Ichinose, Y; Iioka, S; Kato, H; Koike, T; Mori, T; Ohta, M; Sakuma, A; Watanabe, Y | 1 |
Abe, F; Ichimura, E; Nakajima, T; Nishikawa, K; Yamada, M | 1 |
Arai, Y; Endo, M; Ide, H; Isono, K; Makuuchi, H; Mitomi, T; Nabeya, K; Sato, H; Taguchi, G | 1 |
Ashida, C; Gose, K; Hamada, F; Ichiyanagi, A; Imajo, Y; Imanaka, K; Inomata, Y; Kimura, S; Ogawa, Y; Takada, Y | 1 |
Fukuoka, M; Furuse, K; Genka, K; Ishikawa, S; Kato, H; Kinuwaki, E; Nakai, H; Nakano, M; Ohta, M; Tsubura, E | 1 |
Dobashi, K; Ezawa, K; Minato, K | 1 |
Fukuoka, M; Kudo, S; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N | 1 |
Kotake, Y; Nakano, N; Ohshima, S; Tominaga, S; Yasumitsu, T | 1 |
Aso, Y; Kitagawa, M; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
Ikeda, S; Ishihara, K; Taguchi, G | 1 |
5 trial(s) available for ubenimex and Carcinoma, Epidermoid
Article | Year |
---|---|
Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Confidence Intervals; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Survival Analysis; Time Factors; Treatment Failure; Treatment Outcome | 2003 |
[Double blind controlled study of ubenimex (Bestatin) against squamous cell lung cancer--a multicenter cooperative study].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Double-Blind Method; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Rate | 1993 |
Combination therapy with bestatin in inoperable lung cancer. A randomized trial.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1990 |
Bestatin in resected lung cancer. A randomized clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Survival Analysis | 1990 |
[Phase III controlled studies of bestatin in malignant tumors of the skin--results of treatment of squamous cell carcinoma and genital Paget's disease].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Administration Schedule; Female; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Leucine; Male; Middle Aged; Paget Disease, Extramammary; Skin Neoplasms | 1985 |
6 other study(ies) available for ubenimex and Carcinoma, Epidermoid
Article | Year |
---|---|
Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; CD13 Antigens; Chemotherapy, Adjuvant; Female; Fibroblasts; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Leucine; Lung Neoplasms; Lymph Node Excision; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Pneumonectomy; Retrospective Studies; Time Factors; Treatment Outcome | 2009 |
Immunohistochemical expression of aminopeptidase N (CD13) in human lung squamous cell carcinomas, with special reference to Bestatin adjuvant therapy.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; CD13 Antigens; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoenzyme Techniques; Leucine; Lung Neoplasms; Male; Middle Aged; Tissue Array Analysis | 2006 |
[Effect of bestatin on primary tumor and prognosis in patient with esophageal carcinoma].
Topics: Adjuvants, Immunologic; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Leucine; Male; Middle Aged; Prognosis | 1984 |
[Clinical evaluation of bestatin (NK-421) supplementing radiotherapy in the treatment of lung cancer].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage | 1983 |
Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Division; DNA Fragmentation; Humans; Leucine; Lung Neoplasms; Tumor Cells, Cultured | 1996 |
[Hyperthermic treatment with peplomycin and bestatin in superficial bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Hyperthermia, Induced; Leucine; Male; Middle Aged; Peplomycin; Urinary Bladder Neoplasms | 1985 |